MECHANISM OF ARALKYL-DNA ADDUCT FORMATION FROM BENZO[A]PYRENE IN-VIVO

被引:44
|
作者
STANSBURY, KH
FLESHER, JW
GUPTA, RC
机构
[1] UNIV KENTUCKY,DEPT PHARMACOL,GRAD CTR TOXICOL,308 FUNKHOUSER BLDG,LEXINGTON,KY 40506
[2] UNIV KENTUCKY,DEPT PREVENT MED & ENVIRONM HLTH,LEXINGTON,KY 40506
关键词
D O I
10.1021/tx00038a019
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Three different pathways have been propose for the metabolic activation of the ubiquitous polycyclic aromatic hydrocarbon, benzo[a]pyrene (BP). The most widely accepted activation mechanism is based on ring oxidation to diol epoxides; the other two relatively less studied pathways involve radical cation formation and benzylic electrophilic ester formation arising from a chain of substitution reactions. The present study was undertaken to test for the existence of the latter mechanism in vivo. Female Sprague-Dawley weanling rats were injected subcutaneously with 320 mumol of BP/kg body weight, and the formation of DNA adducts was examined. P-32-Postlabeling analysis of the subcutaneous tissue DNA under newly developed chromatography conditions exhibited two sets of adduct profiles: one resulting from alkyl substitution and the other from ring oxidation. One major and two minor aralkyl-DNA adducts were detected. The relative adduct labeling (adducts/10(10) nucleotides) remained constant at around 2 during the first 5 days of treatment and then increased to 6.4 +/- 2.6 at day 7. The corresponding total values of the known ring oxidation (e.g., diol epoxide) adducts were 15-50 times higher. When animals were injected with 6-methyl-BP, 6-(hydroxymethyl)-BP, and 6-(acetoxymethyl)-BP, the known or proposed intermediates in the benzylic ester pathway, each of these and the parent compound showed chromatographically identical profiles of aralkyl-DNA adducts. Cochromatography in multiple solvents of these in vivo adducts with standards prepared by reaction of 6-(bromomethyl)-BP with individual nucleotides showed that the predominant in vivo aralkyl-DNA adduct was derived from guanine while the second major adduct was from adenine. These results provide the first in vivo evidence for the existence of the benzylic ester activation mechanism of polycyclic aromatic hydrocarbons involving alkyl substitution, side-chain hydroxylation, and benzylic ester formation.
引用
收藏
页码:254 / 259
页数:6
相关论文
共 50 条
  • [1] FORMATION AND PERSISTENCE OF BENZO[A]PYRENE DNA-ADDUCTS IN MOUSE EPIDERMIS IN-VIVO - IMPORTANCE OF ADDUCT CONFORMATION
    SUH, M
    ARIESE, F
    SMALL, GJ
    JANKOWIAK, RJ
    HEWER, A
    PHILLIPS, DH
    CARCINOGENESIS, 1995, 16 (10) : 2561 - 2569
  • [2] IN-VIVO DNA ADDUCT FORMATION BY BISPHENOL-A
    ATKINSON, A
    ROY, D
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 1995, 26 (01) : 60 - 66
  • [3] FLUORANTHENE AND PYRENE ENHANCE BENZO[A]PYRENE-DNA ADDUCT FORMATION INVIVO IN MOUSE SKIN
    RICE, JE
    HOSTED, TJ
    LAVOIE, EJ
    CANCER LETTERS, 1984, 24 (03) : 327 - 333
  • [4] Benzo[a]pyrene-mediated DNA adduct formation in bronchoalveolar cells.
    Gelhaus, Stacy Lynn
    Ruan, Qian
    Lee, Seon Hwa
    Penning, Trevor M.
    Blair, Ian A.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2006, 19 (12) : 1682 - 1682
  • [5] Inhibition of benzo[a]pyrene-DNA adduct formation by Aloe barbadensis Miller
    Kim, HS
    Lee, BM
    CARCINOGENESIS, 1997, 18 (04) : 771 - 776
  • [6] METABOLISM OF BENZO[A]PYRENE AND DNA ADDUCT FORMATION IN CULTURED HUMAN EPIDERMAL-KERATINOCYTES
    THEALL, G
    EISINGER, M
    GRUNBERGER, D
    CARCINOGENESIS, 1981, 2 (07) : 581 - 587
  • [7] Modulation of benzo[a]pyrene–DNA adduct formation by CYP1 inducer and inhibitor
    Kazuhiro Shiizaki
    Masanobu Kawanishi
    Takashi Yagi
    Genes and Environment, 39
  • [8] Resveratrol inhibits benzo[a]pyrene–DNA adduct formation in human bronchial epithelial cells
    G Berge
    S Øvrebø
    I V Botnen
    A Hewer
    D H Phillips
    A Haugen
    S Mollerup
    British Journal of Cancer, 2004, 91 : 333 - 338
  • [9] RELATIVE BIOAVAILABILITY AND DNA ADDUCT FORMATION OF BENZO[A]PYRENE AND METABOLITES IN THE DIET OF THE WINTER FLOUNDER
    MCELROY, AE
    CAHILL, JM
    SISSON, JD
    KLEINOW, KM
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY, 1991, 100 (1-2): : 29 - 32
  • [10] ROLE OF ACTIVATED OXYGEN SPECIES IN BENZO[A]PYRENE-DNA ADDUCT FORMATION INVITRO
    BRYLA, P
    WEYAND, EH
    FREE RADICAL BIOLOGY AND MEDICINE, 1991, 11 (01) : 17 - 24